compound glp-1 versions of drugs for weight loss halted by FDA Compounded GLP-1 Training & Drug
Description
Article in the comments #GLP1 #FoodTrends #ConsumerBehavior #CulturalListening #Innovation #Ozempic #TrendForecasting #FMCG #CPGMarketing #FutureOfFood | 12 comments on LinkedIn

Certain genetic variants, carried by around 10 percent of the population, could be making type 2 diabetes GLP-1 treatments (such as Ozempic and Wegovy) less effective, according to new research.

Discover Now!
Avoid common mistakes that can cause discomfort

To minimize selection bias, we employed 1:1 propensity score matching to account for demographic factors such as age, sex, race, and comorbidities
